Molecular dynamics simulation study and hybrid pharmacophore model development in human LTA4H inhibitor design
Human leukotriene A4 hydrolase (hLTA4H) is a bi-functional enzyme catalyzes the hydrolase and aminopeptidase functions upon the fatty acid and peptide substrates, respectively, utilizing the same but overlapping binding site. Particularly the hydrolase function of this enzyme catalyzes the rate-limi...
| Main Authors: | , , , |
|---|---|
| Format: | Journal Article |
| Published: |
2012
|
| Online Access: | http://hdl.handle.net/20.500.11937/7489 |
| _version_ | 1848745383521419264 |
|---|---|
| author | Thangapandian, S. John, S. Arooj, Mahreen Lee, K. |
| author_facet | Thangapandian, S. John, S. Arooj, Mahreen Lee, K. |
| author_sort | Thangapandian, S. |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | Human leukotriene A4 hydrolase (hLTA4H) is a bi-functional enzyme catalyzes the hydrolase and aminopeptidase functions upon the fatty acid and peptide substrates, respectively, utilizing the same but overlapping binding site. Particularly the hydrolase function of this enzyme catalyzes the rate-limiting step of the leukotriene (LT) cascade that converts the LTA4 to LTB4. This product is a potent pro-inflammatory activator of inflammatory responses and thus blocking this conversion provides a valuable means to design anti-inflammatory agents. Four structurally very similar chemical compounds with highly different inhibitory profile towards the hydrolase function of hLTA4H were selected from the literature. Molecular dynamics (MD) simulations of the complexes of hLTA4H with these inhibitors were performed and the results have provided valuable information explaining the reasons for the differences in their biological activities. Binding mode analysis revealed that the additional thiophene moiety of most active inhibitor helps the pyrrolidine moiety to interact the most important R563 and K565 residues. The hLTA4H complexes with the most active compound and substrate were utilized in the development of hybrid pharmacophore models. These developed pharmacophore models were used in screening chemical databases in order to identify lead candidates to design potent hLTA4H inhibitors. Final evaluation based on molecular docking and electronic parameters has identified three compounds of diverse chemical scaffolds as potential leads to be used in novel and potent hLTA4H inhibitor design. © 2012 Thangapandian et al. |
| first_indexed | 2025-11-14T06:16:29Z |
| format | Journal Article |
| id | curtin-20.500.11937-7489 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T06:16:29Z |
| publishDate | 2012 |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-74892017-09-13T14:33:46Z Molecular dynamics simulation study and hybrid pharmacophore model development in human LTA4H inhibitor design Thangapandian, S. John, S. Arooj, Mahreen Lee, K. Human leukotriene A4 hydrolase (hLTA4H) is a bi-functional enzyme catalyzes the hydrolase and aminopeptidase functions upon the fatty acid and peptide substrates, respectively, utilizing the same but overlapping binding site. Particularly the hydrolase function of this enzyme catalyzes the rate-limiting step of the leukotriene (LT) cascade that converts the LTA4 to LTB4. This product is a potent pro-inflammatory activator of inflammatory responses and thus blocking this conversion provides a valuable means to design anti-inflammatory agents. Four structurally very similar chemical compounds with highly different inhibitory profile towards the hydrolase function of hLTA4H were selected from the literature. Molecular dynamics (MD) simulations of the complexes of hLTA4H with these inhibitors were performed and the results have provided valuable information explaining the reasons for the differences in their biological activities. Binding mode analysis revealed that the additional thiophene moiety of most active inhibitor helps the pyrrolidine moiety to interact the most important R563 and K565 residues. The hLTA4H complexes with the most active compound and substrate were utilized in the development of hybrid pharmacophore models. These developed pharmacophore models were used in screening chemical databases in order to identify lead candidates to design potent hLTA4H inhibitors. Final evaluation based on molecular docking and electronic parameters has identified three compounds of diverse chemical scaffolds as potential leads to be used in novel and potent hLTA4H inhibitor design. © 2012 Thangapandian et al. 2012 Journal Article http://hdl.handle.net/20.500.11937/7489 10.1371/journal.pone.0034593 unknown |
| spellingShingle | Thangapandian, S. John, S. Arooj, Mahreen Lee, K. Molecular dynamics simulation study and hybrid pharmacophore model development in human LTA4H inhibitor design |
| title | Molecular dynamics simulation study and hybrid pharmacophore model development in human LTA4H inhibitor design |
| title_full | Molecular dynamics simulation study and hybrid pharmacophore model development in human LTA4H inhibitor design |
| title_fullStr | Molecular dynamics simulation study and hybrid pharmacophore model development in human LTA4H inhibitor design |
| title_full_unstemmed | Molecular dynamics simulation study and hybrid pharmacophore model development in human LTA4H inhibitor design |
| title_short | Molecular dynamics simulation study and hybrid pharmacophore model development in human LTA4H inhibitor design |
| title_sort | molecular dynamics simulation study and hybrid pharmacophore model development in human lta4h inhibitor design |
| url | http://hdl.handle.net/20.500.11937/7489 |